Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Reducing recurrence of advanced melanoma with pembrolizumab
Prof Alex Eggermont - Paris-Sud University, Paris, France
Reducing recurrence of advanced melanoma with pembrolizumab ( Prof Alex Eggermont - Paris-Sud University, Paris, France )
25 Apr 2018
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.
Prof Alex Eggermont - Paris-Sud University, Paris, France
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab. ( Prof Alex Eggermont - Paris-Sud University, Paris, France )
25 Apr 2018
Clinical development and economic prospects of CAR T cell immunotherapies
Dr Bob Velamehr - Fate Therapeutics, La Jolla, USA
Clinical development and economic prospects of CAR T cell immunotherapies ( Dr Bob Velamehr - Fate Therapeutics, La Jolla, USA )
25 Apr 2018
Response and safety profile of neoadjuvant nivolumab for resectable lung cancer
Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA
Response and safety profile of neoadjuvant nivolumab for resectable lung cancer ( Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA )
25 Apr 2018
Doubled survival in metastatic lung cancer with combination therapy
Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Doubled survival in metastatic lung cancer with combination therapy ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018
Combined immuno-chemotherapy improves survival and responses in metastatic lung...
Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018
Results from CheckMate-227 : Immune combination reaches PFS endpoint
Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA
Results from CheckMate-227 : Immune combination reaches PFS endpoint ( Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA )
25 Apr 2018
Editor's Choice for February 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
26 Feb 2018
Integrative analyses to identify genetic determinants of immune responsiveness...
Dr Davide Bedognetti - Sidra Medical and Research Center, Doha, Qatar
Integrative analyses to identify genetic determinants of immune responsiveness in cancer ( Dr Davide Bedognetti - Sidra Medical and Research Center, Doha, Qatar )
21 Feb 2018
Updates on non-metastatic castration-resistant prostate cancer
Prof Kurt Miller, Prof Silke Gillessen, Prof Heather Payne and Dr Eric Small
Updates on non-metastatic castration-resistant prostate cancer ( Prof Kurt Miller, Prof Silke Gillessen, Prof Heather Payne and Dr Eric Small )
8 Feb 2018
Immuno-oncology in breast and cervical cancer
Prof Neal Ready - Duke University School of Medicine, Durham, USA
Immuno-oncology in breast and cervical cancer ( Prof Neal Ready - Duke University School of Medicine, Durham, USA )
29 Jan 2018
Expert insight: Managing neutropenia in breast cancer patients
Dr Matti Aapro and Prof Hope Rugo
Expert insight: Managing neutropenia in breast cancer patients ( Dr Matti Aapro and Prof Hope Rugo )
23 Jan 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation